RBC Capital analyst Gregory Renza maintained a Hold rating on Fulcrum Therapeutics (FULC – Research Report) yesterday and set a price ...

Fintel reports that on November 13, 2024, RBC Capital initiated coverage of Jumia Technologies AG - Depositary Receipt () (NYSE:JMIA) with a Sector Perform recommendation. Analyst Price Forecast ...

In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Mastercard (MA – Research Report), with a price ...

A Donald Trump administration is poised to pull back on regulation in the U.S. banking industry, which is likely to create ...

(Nasdaq: IDCC) announced its participation in the upcoming 2024 RBC Capital Markets Technology, Internet, Media & ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

Donald Trump will return to the White House and will bring major changes to the country's tax, AI and energy policies.

RBC Capital keeps an Outperform rating and $14 price target on Coty after its Q1 like-for-like sale sales growth cut. Unexpected tighter retailer inventory management likely drove downside in the ...

The top 10 underwriters for healthcare issuance accounted for a total of $16.65 billion. RBC Capital Markets ranked No. 1 ...

RBC Capital analyst Deane Dray raised the firm’s price target on Wesco (WCC) to $199 from $186 and keeps a Sector Perform rating on the shares after its Q3 earnings beat. The company’s end ...

RBC Capital raised the firm’s price target on ResMed (RMD) to $232 from $224 and keeps a Sector Perform rating on the shares. The company reported a strong Q1 result with double digit revenue ...

Investing.com - Microsoft's first-quarter results and its current-quarter guidance have left many disappointed investors in ...